Related Articles
A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer
A phase I multicenter study of antroquinonol in patients with metastatic non-small-cell lung cancer who have received at least two prior systemic treatment regimens, including one platinum-based chemotherapy regimen
CARBOPLATIN ASSOCIATED ANEMIA TREATED WITH SUBCUTANEOUS ERYTHROPOIETIN - A PILOT-STUDY
A novel pharmacodynamic approach to assess and predict tumor response to the epidermal growth factor receptor inhibitor gefitinib in patients with esophageal cancer
Pharmacokinetics, pharmacodynamics and metabolism of a novel anticancer agent for prostate cancer